Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02594917 · ClinicalTrials.gov registry record

Genetic and Environmental Determinants That Control Metabolism in Pulmonary Hypertension

A clinical trial, sponsored by University of Pittsburgh.

Completed
Registry status
13
Enrollment target

NCT02594917: Completed study, sponsored by University of Pittsburgh.

NCT02594917 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02594917 has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
13 participants
Enrollment target

Study Summary

The investigators are performing this research study to determine whether having low iron-sulfur cluster levels can cause a disease known as pulmonary hypertension (PH). PH is defined as abnormally high blood pressure in the arteries of the lungs. Usually, small specialized structures inside each human cell called mitochondria are in charge of generating energy within lung arteries for normal function. During situations of disease or stress, lung arteries undergo a change in the function of mitochondria, resulting in the development of PH. In studies on mice, investigators have learned that alterations in the production of specific metal complexes called iron-sulfur clusters are responsible for these changes. This makes it more likely that mice will develop PH. In this study, the investigators want to find out if alteration of iron-sulfur cluster formation leads to increased likelihood of developing PH in humans.

Primary Outcome

In the TEST group, the investigators will measure 6 minute walk distance

Interventions

  • OTHER Blood draw
  • PROCEDURE Right Heart Catheterization

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2015-10
Est. Completion 2023-09-01
University of Pittsburgh

1,238 total trials

What the finished NCT02594917 record still lists

NCT02594917 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target.

The record links to 0 conditions, and to 2 interventions - of which Blood draw is the first listed.

NCT02594917 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02594917 about?

NCT02594917 is a clinical study titled "Genetic and Environmental Determinants That Control Metabolism in Pulmonary Hypertension". The investigators are performing this research study to determine whether having low iron-sulfur cluster levels can cause a disease known as pulmonary hypertension (PH). PH is defined as abnormally high blood pressure in the arteries of the lungs. Usually, small specialized structures inside each h...

What is the current status of trial NCT02594917?

This trial is currently completed. The enrollment target is 13 participants. The study started on 2015-10. Estimated completion is 2023-09-01.

What interventions are being tested in trial NCT02594917?

The interventions under investigation include: Blood draw (OTHER), Right Heart Catheterization (PROCEDURE).

Who is sponsoring clinical trial NCT02594917?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03125655 · 13 participants

    Regulation of Inflammatory Genes in Psoriasis

  • NCT03774446 · 13 participants · Phase 2

    Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease

  • NCT03830151 · 13 participants · Phase 1

    Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors

  • NCT04573231 · 13 participants · Phase 2

    Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02594917, the US trial registry maintained by the National Library of Medicine. NCT02594917 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.